Overview
A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension
Description
A Multi-center, Randomized, Open-label, Active comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared with Losartan in Patients with Diabetic Nephropathy and Hypertension
Eligibility
Inclusion Criteria:
- Male of Female subjects aged ≥19 or <75
- Type II Diabetes Mellitus subjects who have been taken medicine
- Subjects who have voluntarily decided to participate in this clinical trial and Signed ICF
Exclusion Criteria:
- Subjects with Type I Diabetes Mellitus
- Subjects with Primary hyper-aldosteronism
- Subjects with a history of drug or alcohol abuse or suspected patient within 1 year as of the time of screening
- Pregnant women, lactating women, or subjects who do not agree to use appropriate contraception during the clinical trial period
- Subjects who received other clinical trial drugs within 28 days of screening visit
- Subjects who are unable to participate in this clinical trial at the discretion of the investigator.